Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Buprenorphine for Late-Life Treatment-Resistant Depression
NCT02176291Phase 2Completed
- Start
- Aug 2014
- Primary completion
- Apr 2017
- Modality
- Orthosteric Ligands
- Countries
- 1
01
Overview
A Phase 2 trial of buprenorphine in major depressive disorder (MDD). Started Aug 2014; status: completed.
02
Drugs
buprenorphine
03
Conditions
major depressive disorder (MDD)
Beyond the preview
Go deeper on NCT02176291.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02176291.